Document Detail


Platelet function analysis with two different doses of aspirin.
MedLine Citation:
PMID:  20935429     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: We aimed to compare the level of platelet inhibition using the platelet function analyzer (PFA)-100 in patients receiving low and medium doses of aspirin.
STUDY DESIGN: On a prospective basis, 159 cardiology outpatients (83 men, 76 women; mean age 60.9±9.9 years) taking 100 mg/day or 300 mg/day aspirin at least for the previous 15 days were included. Of these, 79 patients (50%) were on 100 mg and 80 patients (50.3%) were on 300 mg aspirin treatment. Blood samples were collected between 09:30 and 11:00 hours in the morning. Platelet reactivity was measured with the PFA-100 system. Incomplete platelet inhibition was defined as a normal collagen/epinephrine closure time (<165 sec) despite aspirin treatment.
RESULTS: Baseline clinical and laboratory characteristics of the patient groups taking 100 mg or 300 mg aspirin were similar. The overall prevalence of incomplete platelet inhibition was 22% (35 patients). The prevalence of incomplete platelet inhibition was significantly higher in patients treated with 100 mg of aspirin (n=24/79, 30.4%) compared with those treated with 300 mg of aspirin (n=11/80, 13.8%) (p=0.013). In univariate analysis, female sex (p=0.002) and aspirin dose (p=0.013) were significantly correlated with incomplete platelet inhibition. In multivariate analysis, female sex (OR: 0.99; 95% CI 0.9913-0.9994; p=0.025) and aspirin dose (OR: 3.38; 95% CI 1.4774-7.7469; p=0.003) were found as independent factors predictive of incomplete platelet inhibition.
CONCLUSION: Our findings suggest that treatment with higher doses of aspirin can reduce incomplete platelet inhibition especially in female patients.
Authors:
Alp Aydınalp; Ilyas Atar; Cihan Altın; Oykü Gülmez; Aslı Atar; Sadık Açıkel; Hüseyin Bozbaş; Aylin Yıldırır; Haldun Müderrisoğlu
Related Documents :
20723029 - High on-aspirin platelet reactivity as measured with aggregation-based, cyclooxygenase-...
17493929 - Platelet activation and myocardial necrosis in patients undergoing radiofrequency and c...
6346519 - The effect of low-dose aspirin and platelet aggregation in familial hypercholesterolaemia.
12846439 - No-aspirin: mechanism of action and gastrointestinal safety.
9693169 - Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting w...
406909 - Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human pl...
7672009 - Lack of platelet-activating factor release on acute myocardial ischemia in the isolated...
17020569 - Aspirin and clopidogrel resistance: consideration and management.
1779939 - A method for determining the total magnesium, calcium, sodium and potassium contents of...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır     Volume:  38     ISSN:  1016-5169     ISO Abbreviation:  Turk Kardiyol Dern Ars     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9426239     Medline TA:  Turk Kardiyol Dern Ars     Country:  Turkey    
Other Details:
Languages:  eng     Pagination:  239-43     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Medicine Faculty of Başkent University, Ankara, Turkey. aydinkalp@superonline.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between admission hemoglobin level and left ventricular systolic functions in patie...
Next Document:  Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coron...